ריוואסטיגמין אינובמד 1.5 מ"ג
Country: Israel
Language: Hebrew
Source: Ministry of Health
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
RIVASTIGMINE AS HYDROGEN TARTRATE 1.5 MG
Available from:
INOVAMED LTD
ATC code:
N06DA03
Pharmaceutical form:
CAPSULES
Administration route:
PER OS
Manufactured by:
ACTAVIS GROUP PTC ehf, ICELAND
Therapeutic group:
RIVASTIGMINE
Therapeutic indications:
Symptomatic treatment of mild to moderately severe Alzheimer's dementia.Symptomatic treatment of mild to moderately severe dementia associated with Parkinson's disease.
Authorization date:
2013-04-01
